Clinical trial
Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults.
NCT00383916 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00383916 |
|---|---|
| Title | Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults. |
| Official title | An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study Between the Altana Formulation of Pantoprazole Delayed-Release Granules and the Wyeth Formulation of Pantoprazole Delayed-Release Granules in Healthy Subjects. |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy Subjects |
| Intervention type | Drug |
| Interventions | pantoprazole |
| Start date | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Oct 4, 2006 |
| Last update posted | Mar 8, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: